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Abstract 
Background: 
Exercise is an effective treatment for patients with sub-acute and chronic low back pain 
(LBP). Patients with a movement control impairment (MCI) can be diagnosed as a subgroup 
of patients with LBP. Unknown is which exercise intervention is most beneficial for this 
subgroup. 
This study assessed the short-term effect of a specific exercise program targeting movement 
control impairment versus general exercise treatment on disability in patients with LBP and 
MCI. 
Methods: In a multicentre parallel group randomised controlled pragmatic trial, patients with 
sub-acute and chronic LBP were included. Further inclusion criteria were disability of ≥5 
points on the Roland-Morris Disability Questionnaire and ≥2 positive tests out of a set of 6 
movement control impairment tests. 
A total of 106 patients were randomly assigned to either tailored movement control exercise 
intervention (MC, n=52) or a general exercise intervention (GE, n=54); both 9-18 individual 
treatment sessions, over a maximum of 12 weeks. . The primary outcome was disability 
measured with the Patient Specific Functional scale (PSFS). Secondary outcome was the 
Roland-Morris disability scale (RMDQ). Measurements were taken pre- and posttreatment. 
Results: No significant difference was found following the treatment period. Baseline-
adjusted between-group mean difference for the PSFS was 0.5 (SD = 0.5; p = 0.32) in favour 
of MC exercises. The Roland-Morris Disability Questionnaire revealed a significant, but not 
clinically relevant, between-group difference of 2.0 points (SD = 0.8; p= 0.01). 
Conclusion: Disability in LBP patients was reduced considerably by both interventions. 
However, the limited contrast between the two exercise programs may have influenced 
outcomes. 
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Introduction 
Societal cost of treatment and absence from work due to low back pain (LBP) are a 
major economic burden (Airaksinen et al., 2006); in Switzerland, an estimated 
fourteen billion Swiss Francs (15 billion US dollars) are spent annually on direct and 
indirect costs due to LBP. In 2007, 41% of the working population in Switzerland 
reported LBP during the previous month (SNF, 2009). In most cases a specific 
diagnosis cannot be identified and the condition is labelled as non-specific low back 
pain (NSLBP)(Grob et al., 2007). Due to the heterogeneity of this patient group, it has 
been recommended to focus research on defining and treating subgroups (Foster et 
al., 2011). 
Within the spectrum of NSLBP, a subgroup of patients with a movement control 
impairment (MCI) can be identified. These patients present with mechanical pain, 
related to movement and positioning of the spine, in combination with an impairment 
of control during movement of the lumbar spine. To allow a more specific 
categorisation, the condition is further classified based on the direction of the 
reported control deficit, i.e. flexion, extension, frontal plane or multidirectional, as 
described by O’Sullivan (O'Sullivan, 2005). The rationale of MCI is based on the 
concept of repeated mechanical overload of tissues in the lower back. The clinical 
diagnosis of these categories showed a good reliability (Dankaerts et al., 2006; 
Fersum et al., 2010). 
Definition and treatment of subgroups requires plausible explanations for concepts or 
models to underpin targeted interventions. The identification of subgroups requires 
clinically feasible and reliable screening procedures (Foster et al., 2011). The validity 
of the clinical diagnosis of the subgroup with MCI and its functional representation is 
gaining increasing support (Dankaerts &  O'Sullivan, 2011; Fersum et al., 2009). To 
further improve the screening procedure for MCI, six active movement tests have 
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been identified in a previous study which showed substantial intra- and interrater 
reliability and represent the clinical classification as described above (Luomajoki et 
al., 2007); validity of the test series was supported by research, showing that two or 
more positive tests, out of a total of six tests, could distinguish between patients with 
LBP and healthy controls (Luomajoki et al., 2008). Results of a case series, in which 
patients were classified as MCI by means of the set of six tests,  showed significant 
improvement in disability and pain when patients were given tailored exercises that 
aimed to improve their control impairment (Luomajoki et al., 2010). However, the 
direct cause-effect relationship between MCI and NSLBP remains unclear. 
 
While exercise as a treatment modality has been shown to be ineffective in the acute 
phase of LBP (< 6 weeks) (Airaksinen et al., 2006; Hayden et al., 2005a; Hayden et 
al., 2005b; Hayden et al., 2005c), several studies support the positive effect of 
exercise on pain and function in sub-acute and chronic pain patients (Hayden et al., 
2005c). The question remains which exercises are most beneficial for which patients. 
Specific exercise programs to treat MCI are widely used in physiotherapy practice. In 
these programs, the impaired control is addressed with individually tailored exercises, 
according to the classification based on MCI tests. The postulated rationale for a 
treatment program for MCI are manifold: A positive influence on mechanically 
induced pain is assumed, due to a decrease of the load on nociceptive innervated 
tissues. Furthermore, improved activity in daily life, due to decreased disability and 
prevention of LBP recurrences, due to increased awareness of body positions 
(Kavcic et al., 2004; Moseley, 2008; Solomonow et al., 2003; Solomonow et al., 
2001) may explain a positive effect. However, evidence for the effectiveness of this 
treatment in a healthcare setting is still lacking. 
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A general exercise program has previously been tested in a sub-acute and chronic 
population in comparison with low-load stabilisation exercises plus general exercise 
(Koumantakis et al., 2005). Results showed that, in the short term, disability was 
reduced to a greater extent by general exercise alone. However, in this study patients 
with all types of NSLBP were included, not only patients with NSLBP and MCI. 
Comparison of an individually tailored, specific MCI treatment against other active 
treatments for this subgroup is lacking. This article reports the short-term results of a 
pragmatic randomised controlled trial (RCT) in outpatient physiotherapy settings on 
disability in LBP patients with MCI, testing the effectiveness of an individualised 
exercise program targeting MCI versus general exercise treatment. 
 
Methods 
Trial Design 
A multicentre parallel group pragmatic RCT was executed in five hospital outpatient 
departments and eight private practices in Switzerland. Patients were recruited 
between August 2010 and February 2012 through referrals from hospitals and 
general practitioners, as well as through advertisements aimed at staff and students 
of the Zurich University of Applied Sciences, Winterthur. The study protocol has been 
published (Saner et al., 2011). 
 
Participants 
Patients (age 18 to 75) presenting with sub-acute or chronic LBP persisting longer 
than six weeks were invited to participate in the baseline screening and assessment 
procedure. Included were patients with MCI complaints, in which pain was provoked 
by movements and static positions of the spine (Mannion et al., 2010). At baseline 
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assessment a minimum score of 5 points on the Roland-Morris Disability 
Questionnaire (RMDQ) was required to ensure at least a minor level of disability 
(Pengel et al., 2004). At least two positive tests out of six MCI tests were required for 
inclusion (Luomajoki et al., 2008, 2010). Patients were excluded (1) when spinal 
pathology was suspected or diagnosed (fractures, carcinoma, nerve root 
compression with neurological signs, e.g. reflex loss, muscle weakness); (2) in case 
of previous spinal surgery or spondylodesis; (3) if comorbid health conditions 
prohibited exercise training. (4) To focus on patients with LBP responding to 
movement, we excluded patients with constant pain and pain below the knee. (5) To 
avoid confounding with high psychosocial factors, patients with scores of more than 
130 on the Örebro Musculoskeletal Pain Screening Questionnaire and more than 3 
months of sick leave due to LBP, were excluded (Linton &  Boersma, 2003). For 
more details see flow chart Fig. 1. 
 
Randomisation and Blinding 
Once informed consent was signed, baseline assessments were taken by an 
independent and specially-trained physiotherapist. The randomisation schedule used 
to assign participants to either movement control (MC) or general exercise (GE) 
treatment group was generated electronically using a block size of four. Allocation to 
treatment of eligible patients was performed (by means of a telephone contact) by a 
research assistant of the university, who was not otherwise involved in the study. 
Blinding of participants and physiotherapists to allocation was not possible due to the 
nature of the treatment. Outcome assessors and data analysts were blinded to 
treatment allocation and were not involved in the interventions. The involved 
therapists and researchers were masked from the outcome measurements and trial 
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results, except for physiotherapists in the MC group, who were informed of the results 
of the initial six physical MCI tests in order to apply MCI direction specific treatment. 
 
Intervention 
Participants in both groups were scheduled for treatment in the outpatient 
departments of the clinics and practices where they had been recruited. 
Movement control (MC) treatment, as illustrated in Appendix, focused on specific 
active exercises to improve the individual movement control impairment as 
diagnosed previously. Initially, participants learned to control the impaired 
movements (either/and in flexion/extension/frontal plane) in closed-chain positions. 
They then progressed to open-chain positions and to exercises with controlled 
movements and increased load. Postural and movement awareness was practiced in 
various situations. Strength training was allowed once control of pain provoking 
movements was achieved. 
General exercise (GE) treatment, as illustrated in Appendix, followed a non-specific 
standardised program, in which strength and endurance of muscles of the 
lumbar/pelvic region and legs were exercised. All relevant muscle groups 
(abdominals, erector spinae, gluteals, quadriceps and hamstrings) were included in 
each treatment session. The progression of exercises followed the guidelines of the 
American College of Sports Medicine (Whaley, 2006). This exercise intervention was 
chosen as the control intervention because of its credibility as a treatment alternative 
for movement-related NSLBP (Hides &  Stanton, 2012). 
 
Treatment description: All participants received individual treatment sessions of 30 
minutes, generally twice per week, for a maximum of 12 weeks. Recommendations of 
twice per week and a maximum of 12 weeks in total were chosen in line with current 
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clinical practice (which includes 9-18 therapy sessions). This allows enough time for 
a comprehensive treatment which is effective in achieving optimal changes of 
movements and tissues. 
Treatment progression followed a pragmatic approach and was determined by the 
clinical judgement of the physiotherapist. In each session, a timespan of maximal 10 
minutes was allowed for other physiotherapy applications; duration (minutes) and 
types of interventions were recorded. All participants should have mastered at least 
three home-exercises by the end of treatment. Two regular exercise sequences per 
week of self-directed home-exercise were strongly recommended for the following 
year. 
The main contrast between the two treatments was the instruction of specifically and 
individually tailored movement control exercises applied in the MC group, as opposed 
to the generalised approach in the GE group. 
The physiotherapists treating the MC group were either qualified to OMT 
(Orthopaedic manual therapy) standards or novices working under supervision of 
experts at the university. 
All therapists underwent at least four hours of training on the study procedures and 
received a manual of exercise interventions. Therapists reported on exercise 
programs, number of home exercises and minutes of other interventions for each 
patient in a written log. 
 
Baseline Descriptives 
Demographic data, including age, sex, height, weight, sports activities, workload, 
work status, medication usage and duration of symptoms, were documented. 
Descriptive measures also included the Fear-Avoidance Beliefs Questionnaire 
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(FABQ)(Sieben et al., 2005; Staerkle et al., 2004) and the Graded Chronic Pain 
Scale (GCPS) version 2.0 with subscales for pain intensity, disability and state of 
chronicity (Turk, 2011). 
 
Outcome Measures 
Measurements were taken at baseline and after treatment (see flowchart Fig1.). The 
primary outcome was LBP-related disability as measured with the Patient-Specific 
Functional Scale (PSFS) (Hall et al., 2011; Stratford P, 1995). PSFS was chosen as 
the primary outcome, because it represents the clinical reality and personal relevance 
for patients, as it refers to the activity which is most important in limiting daily life. 
Additionally, clinimetric studies regarded PSFS as more responsive than RMDQ in 
patients with mild NSLBP (Horn et al., 2012; Pengel et al., 2004). 
The secondary outcome measure was disability, as measured with the Roland-Morris 
Disability Questionnaire (RMDQ). More details on the outcome measures are 
described in the study protocol (Saner et al., 2011). 
 
Sample Size Calculation 
Based on a previous case series (Luomajoki et al., 2010), sample size was 
calculated in order to detect a mean difference between the two groups of 0.9 points 
on the PSFS, with an assumed standard deviation of 1.5 points. With alpha set at 
0.05 and statistical power at 90%, 48 participants were required in each group. 
Accounting for a drop-out rate of 10%, 106 participants were included. 
Data Analysis 
Descriptive statistics of demographic data and clinical measures were performed. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
10 
 
Given the finding that on the PSFS the correlation between the average of three 
activities and the first activity mentioned by the patient was very high (0.9), the value 
of only the first activity was used in further analysis. 
Analyses were performed according to intention-to-treat principles. Missing values 
after treatment were substituted by group average. For between-groups analyses, 
mean differences between baseline and short-term measurements, their SDs and 
confidence intervals were calculated, followed by a one-way between-group analysis 
of variance for each clinical outcome. Influences of baseline differences between the 
groups, and of potentially confounding variables were assessed with analysis of 
covariance. All analyses were conducted using IBM SPSS Statistics 20. Two-sided 
significance for all values was set at p<0.05. 
Based on literature, a minimal clinically important difference for slightly disabled LBP 
participants was set a priori, at 30% of baseline score for PSFS and RM (Dworkin et 
al., 2009; Maughan &  Lewis, 2010; Saner et al., 2011). Relative risk (RR) and 
number needed to treat (NNT) were calculated. 
 
Results 
Participants 
A total of 201 patients were evaluated for eligibility. Reasons for exclusion (n=48) are 
described in the flow chart in figure 1. A total of 153 patients were assessed for 
baseline variables, of which 47 were excluded, mainly because of not meeting 
minimal requirements for RMDQ (n=24) and MC test series (n=12). The remaining 
106 participants were randomized (MC=52, GE=54). Baseline characteristics across 
groups (see table 1) were well balanced, except that the MC group had longer pain 
duration. 
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Insert Figure 1: Flow chart about here 
 
Measurements after treatment were taken in 41/49 MC/GE cases respectively. Three 
participants in the MC group and two in the GE group either withdrew from the study 
or were lost to follow up. Seven participants in the MC group and three in the GE 
group finished treatment but were not assessed post-treatment. Baseline 
characteristics did not differ between assessed and non-assessed participants, 
except for the duration of pain. 
 
Insert Table 1 Baseline demographic data and baseline results of 
questionnaires about here 
 
Adherence  
Seventy-nine (74.5%) treatment logs (MC=41; GE=38) were returned by 
physiotherapists for analysis. The mean number (SD) of treatment sessions for MC 
and GE groups was 8.4(2.9) and 8.8(3.4) respectively; the number of home exercises 
recommended at end of treatment was 3.9(1.3) and 5.0(2.7), respectively. 
Participants in both groups started with a mean number of impaired movement 
control tests of 3.9; after treatment the MC group improved to a mean of 1.8 and the 
GE participants to 2.8 positive tests. 
 
Primary outcome 
There was no statistically significant difference on the PSFS between the two 
exercise groups after treatment (p=0.32; see table 2). Based on literature and 
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baseline differences, pain intensity, pain duration and baseline PSFS were tested for 
their influence on group differences (primary outcome) using univariate analysis of 
variance. The baseline PSFS was identified as a potentially influencing factor 
(p<0.001). Analysis of covariance (ANCOVA) showed no significant change on the 
primary outcome, however. 
 
Insert Table 2 Results of disability scores about here 
 
Secondary outcome 
For the RM a significant difference in mean change scores between the two groups 
was found (mean=2.0; 95%CI=0.4-3.5; p=0.01). 
 
Minimal Clinically Important Difference 
The minimal clinically important difference, defined a priori as 30% of the baseline 
scores, was 1.26 and 2.7 for the PSFS and RM respectively (Dworkin et al., 2009). 
Concerning the absolute number of participants with a clinically significant change, 
no significant difference could be found at follow-up for both variables (Table 2). 
However, as table 3 shows, relative risk, the factor reflecting improvement, differed in 
favour of the MC group for both outcomes with PSFS/RM;1.25/1.39 respectively. The 
average number of participants who need to be treated to provide improvement with 
MC is shown as numbers needed to treat (PSFS/RM;7/5). 
 
Insert Table 3 Participants with a minimal clinical important difference about here 
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Co-interventions 
Four participants (1 in GE and 3 in MC) reported additional self-financed treatments 
(acupuncture, massage) during the treatment period. 
 
Work Status and Return to Work 
Of the 12 participants who were on sick leave due to LBP at baseline, eight returned 
to unrestricted work post-treatment. One participant in the GE group (id73) remained 
on restricted work status. Three participants who were initially on sick leave withdrew 
from the study for personal reasons. Work status post-treatment was not reported by 
three participants. 
 
Discussion 
This multicentre randomised controlled trial is, as far as we know, the first study to 
uniquely include NSLBP participants with MCI. Differences in primary outcome 
between the MC and GE groups were small and insignificant. Only between-group 
differences in improvements on the Roland-Morris questionnaire, the secondary 
outcome, reached significance. Both groups improved substantially in all treatment 
outcomes. Given the positive natural course of NSLBP, this improvement was to be 
expected. 
 
Methodological Limitations 
Several limitations of this study must be noted. Since recruitment from participating 
practices was below expectations, thirty participants were recruited among staff and 
students of the university through an additional internal advertisement. These 
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participants were not referred by a physician. However, analysis showed that these 
participants were comparable to referred patients for baseline characteristics and 
outcomes. 
Sixteen participants were not assessed post-treatment. Six withdrew from the study 
or developed other illnesses. Final assessment after participants had completed their 
treatment was not possible in ten cases for logistic reasons, since the procedure 
required an additional consultation with an independent assessor. 
To improve recruitment from participating physiotherapists, the protocol allowed for a 
maximum of ten minutes per treatment session to be used for other techniques, such 
as muscle stretching and mobilisation. Log books showed a wide variety of additional 
interventions, which was comparable in both groups. Our research aim was to 
evaluate, whether for a specific subgroup of patients with MCI, a MCI intervention is 
more effective than a general exercise physical therapy program. These strict design 
choices may have diminished the treatment contrast between groups. For example, a 
comparison of MCI exercise versus usual care by a physician, prescribing physical 
therapy only in a few cases, might yield larger between-group differences. However, 
the design used for this RCT to our opinion best reflects current treatment choices in 
everyday physical therapy practice. 
Other possible influences on the results could originate from treatment frequency and 
number of treatment sessions. A treatment frequency of 2 sessions per week was a 
recommendation rather than a rule; the number of sessions was reported in the log 
book and showed no difference between the groups. Similarly the number of home 
exercises is comparable in both groups. Controlling the quality of and adherence to 
exercise during the treatment phase was up to the physiotherapist. However, we 
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think the influences are comparable in both groups and we have no reason not to 
believe the reports of patients or therapists. 
 
Theoretical and Clinical Implications 
We used two measures of disability (PSFS, RMDQ). PSFS did not show significant 
between-group differences, while difference in RMDQ was significant. The PSFS was 
chosen as primary outcome, because in previous research sensitivity to change was 
reported to be higher than for the RMDQ in participants with low levels of disability 
(Beurskens et al., 1999; Pengel et al., 2004). With the PSFS the patient individually 
selects his limited activities, which we expected to be more responsive for disability 
outcome. 
The RMD questionnaire, on the other hand, assesses the disability over the past 48 
hours using 24 standard items, to be valued in a dichotomous manner. With a mean 
of eight to nine points at baseline, our patient sample was only mildly affected. 
Although a floor effect could be expected, the short term between-group difference in 
RMDQ improvement was significant in favour of the MC group. 
 
We had planned to evaluate disability using the average of three PSFS activities. 
However, several participants were unable to name three activities. A frequent 
reason was, that participants mentioned activities that were not currently performed 
(snow shovelling or digging the garden), making these activities unsuitable for the 
assessment of disability during the past week. Therefore, we assessed correlations 
and found a very high correlation (0.9) between the first activity mentioned and the 
average of the maximal three activities. To ease the evaluation process, we 
proceeded with only the first activity mentioned in all further analysis. 
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Between-group differences for the minimal clinically important change were smaller 
than the a priori set level of 30%. However, on evaluation of participants with a 
minimal clinically important change of improvement, 77% of participants within the 
MC group improved more than the determined 30% for both outcomes. The general 
exercise group improved 61% for PSFS and 55% for RMDQ above minimal clinical 
importance. This resulted in numbers needed to treat of 7/5 patients in favour of the 
movement control treatment, when measured with PSFS or RMDQ respectively. 
 
This study showed that in the short-term, movement control exercise was not 
significantly superior to general exercise for patients with MCI. One reason could be 
the low contrasts between the two treatment programs. Although MC and GE 
exercises were distinctly different at the beginning of the intervention, there was an 
increasing similarity of exercises between the two programs as treatment progressed. 
MC treatment progression shifted from closed chain to open chain exercises, with 
incremental loading, introducing strengthening components. GE treatment focused 
on strength without specifically paying attention to movement control impairments. 
A second explanation for the non-significant differences in outcome may be that, in 
patients with positive MCI tests, the loss of movement control is not the only factor 
contributing to NSLBP. Treatments in this study focused on the physical functional 
impairment of movement. Through the addition of cognitive characteristics to 
subgroup definition and treatment, as recently proposed, predictive models and 
patient outcomes may improve (O'Sullivan, 2012).  
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Theoretical background 
The physiological and cognitive rationales for movement control exercise have not 
been widely validated and are based on smaller studies. The physiological rationale 
of reducing mechanical overload on connective tissue, caused by uncontrolled 
movements, has been proposed by Kavic (Kavcic et al., 2004). In the current study, 
the attempt to control the load through improved muscular coordination, which 
resulted in a reduction in the number of positive MCI tests and improved disability, 
was achieved with both types of intervention. 
The intervention using MC exercises also addressed body and movement 
awareness, positive experiences with pain-free movement and explanations for the 
improved movement control. These cognitive aspects may have had a potential 
impact on the reorganisation of the cerebral cortex representing areas of the low 
back and on the reversal of central sensitisation processes in the nervous system 
(Nijs et al., 2010; Voss et al., 2010; Wand et al., 2011). However, questions about 
changes in the nervous system could not be answered in the current study. 
 
Conclusion 
This randomized controlled trial, comparing 9-12 weeks of specific movement control 
training to general exercise, showed no difference in improvement of LBP disability. 
Future research should extend the criteria for the definition of clinical subgroups 
among patients with LBP, as well as further develop treatments focused on these 
subgroups. Distinctly different exercise programs are essential in future investigations 
concerning the question, “Which exercise is best for whom?”. We recommend 
longitudinal studies to explore cognitive changes in patients with impaired movement 
control and NSLBP as well as treatment-induced biological changes.  
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Figure 1 Flow chart of participants through the trial 
Participants checked for eligibility by 
telephone
n = 201
Excluded n = 48
Older than 75 years of age
n = 5
< 6 wKs with pain n = 3
Constant pain n = 7
> 3 months off work n = 2
Other illness;
surgery recent n = 17
pain below knee n = 6
not fluent in German n = 8Baseline assessment
for subgroup
n = 153
Eligible subjects 
randomised 
n = 106
Excluded n = 47
<5 Roland Morris n = 24
<2 Movement Control Tests 
n = 12
no consent n = 2
no reason n = 4
logistic/no time/no referral 
n = 5
Allocated to Movement Control  
n = 52
Allocated to General Exercise
n = 54
Received allocated intervention 
n = 48
Withdrawn/lost to follow up n = 3
Discontinued other illness n = 1
Received allocated intervention 
n = 52
Withdrawn/lost to follow up n = 2
Assessed posttreatment n = 41
Non response n = 7
Analysed n = 52
Assessed posttreatment n = 49
Non response n = 3
Analysed n = 54
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Table 1 Baseline demographic data and baseline results of questionnaires 
 
 
 Movement 
Control 
n = 52 
General 
Exercise 
n = 54 
Total 
Group  
n = 106 
Age (y) mean (SD) 42.8 (13.8) 40.5 (14.7) 41.6 (1.4) 
Gender female, n 16 24 40 
Height (cm) mean (SD) 173.0 (8.5) 173.9 (8.0) 173.6 (8.3) 
Weight (kg) mean (SD) 75.5 (11.7) 74.7 (11.9) 75.4 (12.1) 
Physical workload low, n 23 (44.2%) 21 (38.9%) 44 (41.5%) 
 medium, n 22 (42.3%) 26 (48.1%) 48 (45.3%) 
 heavy, n 5 (9.6%) 6 (11.1%) 11 (10.4%) 
 missing, n 2 (3.8%) 1 (1.9%) 3 (2.8%) 
Sport participation No, n 19 (36.5%) 16 (30.8%) 35 (33.0%) 
 1– 2x week, n 21 (42.0%) 23 (43.1%) 44 (41.5%) 
 > 2x week, n 10 (20.0%) 13 (25.0%) 23 (21.7%) 
 missing, n 2 (3.8%) 2 (3.8%) 4 (3.8%) 
Work status sick leave, n 1 (1.9%) 5 (9.3%) 6 (5.7%) 
 part-time 
leave, n 
3 (5.8%) 3 (5.6%) 6 (5.7%) 
 full-time, n 39 (75.0%) 38 (70.4%) 77 (72.6%) 
 no paid job, n 5 (9.6%) 8 (14.8%) 13 (12.3%) 
 missing, n 4 (7.7%) 0 4 (3.8%) 
Pain Duration* (y) mean (SD) 11.6 (12.8) 8.4 (8.9) 10.0 (11.0) 
 < 1 year, n 4 8 12 (11.3%) 
 1 – 5 years, n 17 15 32 (30.2%) 
 > 5 years, n 26 27 53 (50.0%) 
 missing, n 5 4 9 (8.5%) 
ÖMPQ mean (SD) 78.3 (24.3) 81.5 (20.4) 79.9 (22.3) 
FABQ Total mean (SD) 29.9 (13.7) 34.7 (15.4) 32.3 (14.7) 
 missing, n 2 (3.8%) 3 (5.6%) 5 (4.7%) 
 mean (SD) 25.9 (9.8) 29.5 (11.0) 27.8 (10.4) 
GCPS  Pain           
Intensity score 
mean (SD) 14.7 (4.7) 16.5 (4.2) 15.6 (4.5) 
GCPS  Disability 
score 
mean (SD) 11.5 (7.2) 13.3 (8.3) 12.4 (7.6) 
GCPS  Chronic 
Pain score 
Grade I, n 21 (41.2%) 16 (30.8%) 37 (35.9%) 
 Grade II, n 17 (33.3%) 20 (38.5%) 37 (35.9%) 
 Grade III, n 10 (19.6%) 11 (21.2%) 21 (20.4%) 
 Grade IV, n 3 (5.9%) 5 (9.6%) 8 (7.8%) 
 missing, n 1 (1.9%) 2 (3.7%) 3 (2.8%) 
 
* Overall duration of LBP 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
23 
 
 
ÖMPQ: Oerebrö musculoskeletal pain questionnaire (Linton &  Boersma, 2003) 
FABQ: Fear-avoidance beliefs questionnaire - 0 (low fear); 96 (highest fear) (Sieben 
et al., 2005; Staerkle et al., 2004) 
GCPS: Graded Chronic Pain Scale: subscale for pain (0-30); subscale for disability 
(0-40); subscale for pain grade (0-IV;0=no pain, no disability; IV=high disability) 
(Turk, 2011) 
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Table 2 Results of disability scores pre- and post-treatment and between-group 
differences  
 
 Pre- 
treatment 
Post-treatment Difference between groups 
post-treatment (change 
scores pre-post-treatment) 
Outcomes MC 
(n=52) 
mean 
(SD) 
GE 
(n=54) 
mean (SD) 
MC 
(n=52) 
mean (SD) 
GE 
(n=54) 
mean (SD) 
Mean (SD, 
95%CI) 
p-value 
PSFS activity1 4.3 (1.9) 4.0 (2.0) 7.4 (1.9) 6.6 (2.2) 0.5 (0.5)-0.5-
1.5 
0.32 
RMDQ 
 
9.1 (3.2) 8.2 (3.3) 4.2 (3.7) 5.2 (4.0) 2.0 (0.8) 0.4-3.5 0.01** 
 
MC: Movement control group GE: General exercise group 
PSFS: Patient-Specific Functional Scale self-score activity mentioned first, ranging 
from 0 (unable to perform) to 10 (able to perform without difficulties) 
RMDQ: Roland-Morris Disability Questionnaire score, ranging from 0 (no difficulties) 
to 24 (extreme difficulties)  
SD: standard deviation. CI: confidence interval 
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Table 3 Patients with a minimal clinically important difference post-treatment; relative 
risk and number needed to treat (NNT) for clinical important improvement  
 
Outcomes Total group 
(n=106) n(%) 
MC group 
(n=52) n(%) 
GE group 
(n=54) n(%) 
Relative risk 
(95%CI) 
NNT 
PSFS 73 (68.9) 40(76.9) 33(61.1) 1.25(0.97-1.42) 7 
RMDQ 70 (66.0) 40(76.9) 30(55.6) 1.39 (1.04-
1.83) 
5 
 
MC: Movement control group; GE: General exercise group; PSFS: Patient-Specific 
Functional Scale; RMDQ: Roland-Morris Disability Questionnaire; CI: confidence 
interval; NNT: numbers needed to treat 
 
  
